Elbit Imaging Ltd. Announces CMS Coverage for Insightec's MR-Guided Focused Ultrasound Treatment for Essential Tremor Expand to Additional States

Author's Avatar
Apr 12, 2019
Article's Main Image

TEL AVIV, ISRAEL / ACCESSWIRE / June 4, 2018 / Elbit Imaging Ltd. (TASE: EMITF; NASDAQ: EMITF) ("Elbit" or the "Company") announced today (further to the information in the Company's Form 20-F for the fiscal year ended December 31, 2017, under Item 4.B (the caption "Insurance coverage"), that Insightec Ltd. ("Insightec") informed that CMS benefit coverage will be available to patients in U.S. for MR-guided focused ultrasound ("MRgFUS") for the treatment of essential tremor in six more states starting from July 1, 2018.